| Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma G Lou, X Song, F Yang, S Wu, J Wang, Z Chen, Y Liu Journal of hematology & oncology 8, 1-11, 2015 | 707 | 2015 |
| Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases G Lou, Z Chen, M Zheng, Y Liu Experimental & molecular medicine 49 (6), e346-e346, 2017 | 615 | 2017 |
| MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway G Lou, L Chen, C Xia, W Wang, J Qi, A Li, L Zhao, Z Chen, M Zheng, Y Liu Journal of Experimental & Clinical Cancer Research 39, 1-9, 2020 | 258 | 2020 |
| AMSC-derived exosomes alleviate lipopolysaccharide/d-galactosamine-induced acute liver failure by miR-17-mediated reduction of TXNIP/NLRP3 inflammasome activation in macrophages Y Liu, G Lou, A Li, T Zhang, J Qi, D Ye, M Zheng, Z Chen EBioMedicine 36, 140-150, 2018 | 211 | 2018 |
| MiR‐122 modification enhances the therapeutic efficacy of adipose tissue‐derived mesenchymal stem cells against liver fibrosis G Lou, Y Yang, F Liu, B Ye, Z Chen, M Zheng, Y Liu Journal of cellular and molecular medicine 21 (11), 2963-2973, 2017 | 204 | 2017 |
| BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8+ T cells Nat Immunol ., 2021 | 130 | 2021 |
| The p53/miR-34a/SIRT1 positive feedback loop in quercetin-induced apoptosis G Lou, Y Liu, S Wu, J Xue, F Yang, H Fu, M Zheng, Z Chen Cellular Physiology and Biochemistry 35 (6), 2192-2202, 2015 | 127 | 2015 |
| Role of miR-223 in the pathophysiology of liver diseases D Ye, T Zhang, G Lou, Y Liu Experimental & molecular medicine 50 (9), 1-12, 2018 | 117 | 2018 |
| Plasma miR-17, miR-20a, miR-20b and miR-122 as potential biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus patients D Ye, T Zhang, G Lou, W Xu, F Dong, G Chen, Y Liu Life sciences 208, 201-207, 2018 | 84 | 2018 |
| MicroRNA-141 targets Sirt1 and inhibits autophagy to reduce HBV replication Y Yang, Y Liu, J Xue, Z Yang, Y Shi, Y Shi, G Lou, S Wu, J Qi, W Liu, ... Cellular Physiology and Biochemistry 41 (1), 310-322, 2017 | 60 | 2017 |
| lncRNA MALAT1 modulates cancer stem cell properties of liver cancer cells by regulating YAP1 expression via miR-375 sponging L Zhao, G Lou, A Li, Y Liu Molecular medicine reports 22 (2), 1449-1457, 2020 | 46 | 2020 |
| Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway G Lou, X Dong, C Xia, B Ye, Q Yan, S Wu, Y Yu, F Liu, M Zheng, Z Chen, ... Journal of Experimental & Clinical Cancer Research 35, 1-10, 2016 | 44 | 2016 |
| MiR-144-3p-mediated dysregulation of EIF4G2 contributes to the development of hepatocellular carcinoma through the ERK pathway S Li, J Shao, G Lou, C Wu, Y Liu, M Zheng Journal of Experimental & Clinical Cancer Research 40, 1-14, 2021 | 34 | 2021 |
| Neddylation inhibitor MLN4924 has anti‐HBV activity via modulating the ERK‐HNF1α‐C/EBPα‐HNF4α axis M Xie, H Guo, G Lou, J Yao, Y Liu, Y Sun, Z Yang, M Zheng Journal of Cellular and Molecular Medicine 25 (2), 840-854, 2021 | 34 | 2021 |
| MicroRNA-223 acts as an important regulator to Kupffer cells activation at the early stage of Con A-induced acute liver failure via AIM2 signaling pathway F Yang, G Lou, X Zhou, M Zheng, J He, Z Chen Cellular Physiology and Biochemistry 34 (6), 2137-2152, 2014 | 32 | 2014 |
| Isoliquiritigenin inhibits interferon-γ-inducible genes expression in hepatocytes through down-regulating activation of JAK1/STAT1, IRF3/MyD88, ERK/MAPK, JNK/MAPK and PI3K/Akt … S Wu, J Xue, Y Yang, H Zhu, F Chen, J Wang, G Lou, Y Liu, Y Shi, Y Yu, ... Cellular Physiology and Biochemistry 37 (2), 501-514, 2015 | 31 | 2015 |
| Interferon-α sensitizes HBx-expressing hepatocarcinoma cells to chemotherapeutic drugs through inhibition of HBx-mediated NF-κB activation Y Liu, G Lou, W Wu, Y Shi, M Zheng, Z Chen Virology journal 10, 1-11, 2013 | 31 | 2013 |
| SPAG9 is involved in hepatocarcinoma cell migration and invasion via modulation of ELK1 expression Q Yan, G Lou, Y Qian, B Qin, X Xu, Y Wang, Y Liu, X Dong OncoTargets and therapy, 1067-1075, 2016 | 28 | 2016 |
| APOBEC3G directly binds Hepatitis B virus core protein in cell and cell free systems D Zhao, X Wang, G Lou, G Peng, J Li, H Zhu, F Chen, S Li, D Liu, Z Chen, ... Virus research 151 (2), 213-219, 2010 | 27 | 2010 |
| The Sterile Inflammation in the Exacerbation of HBV‐Associated Liver Injury Q Yang, Y Shi, Y Yang, G Lou, Z Chen Mediators of Inflammation 2015 (1), 508681, 2015 | 26 | 2015 |
yanning liuzhejiang universityCorreu electrònic verificat a zju.edu.cn
